HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zong-Chao Liu Selected Research

manumycin

8/2005[Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
12/2003Manumycin induces apoptosis in human hepatocellular carcinoma HepG2 cells.
6/2003Manumycin inhibits cell proliferation and the Ras signal transduction pathway in human hepatocellular carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zong-Chao Liu Research Topics

Disease

11Neoplasms (Cancer)
05/2012 - 02/2002
5Leukemia
01/2008 - 02/2002
4Hepatocellular Carcinoma (Hepatoma)
08/2005 - 06/2003
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2005
2Carcinogenesis
05/2012 - 08/2003
2Myeloid Leukemia (Leukemia, Myelocytic)
10/2006 - 12/2005
2Osteosarcoma (Osteogenic Sarcoma)
01/2005 - 06/2004
2Nasopharyngeal Carcinoma
04/2003 - 05/2002
1Hematoma
11/2018
1Cerebral Hemorrhage
11/2018
1Hemorrhage
11/2018
1Intervertebral Disc Degeneration
07/2018
1Inflammation (Inflammations)
06/2018
1Temporal Lobe Epilepsy
02/2014
1Status Epilepticus (Complex Partial Status Epilepticus)
02/2014
1Lymphoma (Lymphomas)
01/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2008
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2005
1Adenocarcinoma of Lung
12/2005
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2005
1Liver Neoplasms (Liver Cancer)
12/2005
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2005
1Colonic Neoplasms (Colon Cancer)
08/2005
1Anaplastic Thyroid Carcinoma
08/2005
1Breast Neoplasms (Breast Cancer)
08/2003

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
05/2012 - 05/2002
3Caspase 3 (Caspase-3)IBA
07/2010 - 02/2002
3manumycinIBA
08/2005 - 06/2003
2duhuo jishengIBA
07/2018 - 06/2018
2ErbB-2 ReceptorIBA
05/2012 - 08/2003
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2012 - 08/2003
2Phosphotransferases (Kinase)IBA
07/2010 - 05/2005
2rhabdastrellic acid AIBA
01/2008 - 08/2007
2IodidesIBA
10/2006 - 02/2004
2DNA Primase (Primase)IBA
10/2006 - 02/2004
1LipidsIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
11/2018
1Pilocarpine (Ocusert)FDA LinkGeneric
02/2014
1EnzymesIBA
02/2014
1houttuyninumIBA
05/2012
1Messenger RNA (mRNA)IBA
07/2010
1alkanninIBA
07/2010
1Apoptosis Regulatory ProteinsIBA
01/2008
1GossypolIBA
01/2008
1SYUNZ-7IBA
12/2005
1N-methylisoindigotinIBA
12/2005
1TransferasesIBA
08/2005
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
05/2005
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2005
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2005
1Protein Isoforms (Isoforms)IBA
01/2005
1Paclitaxel (Taxol)FDA LinkGeneric
01/2005
1Etoposide (VP 16)FDA LinkGeneric
06/2004
1Farnesyltranstransferase (Farnesyltransferase)IBA
12/2003
1Tyrosine (L-Tyrosine)FDA Link
08/2003
1N-(4-ethoyphenol)-2-hydroxy- acid amideIBA
08/2003
1CeramidesIBA
04/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2002
1Epirubicin (Ellence)FDA LinkGeneric
05/2002
1squamocinIBA
02/2002
1AcetogeninsIBA
02/2002

Therapy/Procedure

1Aftercare (After-Treatment)
01/2005
1Drug Therapy (Chemotherapy)
05/2002